Disease | hepatitis b |
Phenotype | C1561644|chronic kidney disease (ckd) |
Sentences | 1 |
PubMedID- 24299322 | Background: the treatment of chronic hepatitis b (chb) in patients with chronic kidney disease (ckd) is based on nucleoside (lamivudine, telbivudine, entecavir) or nucleotide (adefovir, tenofovir) analogues (nas), but it may be complex and the information is scarce. |
Page: 1